Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Running, not enrolling · Not applicable
Conditions studied: Cancer
In brief
Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites and assess the impact of Home ePRO on clinical and utilization outcomes.
Key facts
- Study ID
- NCT04809740
- Run by
- University of Alabama at Birmingham
- People needed
- 3090
- Starts
- 2021-05-04
- Expected to finish
- 2027-02-28
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patient Group:
- Age ≥18
- Cancer patients at participating institution
- Receipt of chemotherapy, targeted therapy, and immunotherapy at participating institution from 2019-2026.
You may not qualify if…
- Second opinion only at participating institution.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.